银化物Rg1通过Keap1/Nrf2信号通路调节炎症反应和骨重塑,用于患有牙周炎的老鼠
Yang Zhou1,2, Yunan Zhang1,2, Li Wang1,2
1Department of Oral Prosthodontics, The Affiliated Stomatological Hospital of Southwest Medical University, 2 Jiangyang South Road, Luzhou, 646000, Sichuan, People's Republic of China.
Scientific reports
|March 3, 2025
概括
金色化物Rg1 (GS-Rg1) 通过减少炎症和促进骨生长,有效治疗牙周炎. 这项研究揭示了GS-Rg1.
科学领域:
- 牙周病学 牙周病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 牙周炎是一种慢性炎症性疾病,影响口腔组织.
- 人参提取物Ginsenoside Rg1 (GS-Rg1) 具有抗炎和骨质生成的功效.
- 对于牙周炎的GS-Rg1的治疗潜力及其机制尚不清楚.
研究的目的:
- 为了研究GS-Rg1在牙周炎的老鼠模型中的疗效.
- 阐明GS-Rg1在牙周炎中的作用的潜在分子机制.
主要方法:
- 在老鼠中使用Porphyromonas gingivalis注射的正牙线诱导牙周炎.
- 评估了炎症标志物 (IL-6,TGF-β1),骨质细胞活性和骨质原因子 (RUNX2,OCN).
- 使用微型CT和H&E染色来评估牙周组织的破坏.
- 通过Western Blot和RT-PCR分析了Keap1/Nrf2通路蛋白质表达.
主要成果:
- GS-Rg1显著降低了IL-6和增加了TGF-β1的分泌.
- GS-Rg1降低了骨质细胞数量,并增强了RUNX2和OCN的表达.
- GS-Rg1上调Nrf2和下调Keap1表达,表明Keap1/Nrf2通路的激活.
结论:
- 在临床前牙周炎模型中,GS-Rg1显示出显著的治疗效果.
- GS-Rg1通过调节炎症反应和通过Keap1/Nrf2通路促进骨质生成来缓解牙周炎.
- GS-Rg1显示出作为治疗牙周炎的新型治疗剂的前景.
相关概念视频
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K


